CSA Medical Announces Expansion of truFreeze(R) Label to Include Barrett's Esophagus with Low Grade Dysplasia

From Barrett's Esophagus to Malignancy - Only truFreeze® BOSTON, Aug. 31, 2017 -- (Healthcare Sales &Marketing Network) -- CSA Medical announced on Thursday, the expansion of its truFreeze® label with the addition of Barrett's Esophagus with l... Devices, Interventional, FDA CSA Medical, truFreeze, Barrett's Esophagus, cryotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

Conclusion Salvage cryotherapy appears safe and effective for treating BE that is refractory to RFA and/or EMR. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents  |  Abstract  |  open access Full text
Source: Endoscopy International Open - Category: Gastroenterology Authors: Tags: Original article Source Type: research
Duodenal adenomas (DA) can progress to high grade dysplasia (HGD) in 21% of cases. When> 2 cm in size, more than half can harbor invasive cancer. Familial adenomatous polyposis (FAP) patients are at high risk for duodenal cancer arising from DA. Endoscopic mucosal resection (EMR) is generally the preferred treatment but is associated with an overall adverse event rate of 26%, primarily from bleeding, particularly those>3 cm in size (incidence 33-58%). Cryotherapy using the focal cryoballoon ablation system (C2 Cryoballoon ®, Pentax) can safely and effectively eradicate esophageal intestinal metaplasia with dysplasia.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Sunday abstract Source Type: research
Dysphagia is a predominant symptom in patients with locally advanced esophageal cancer, with limited palliative options for symptom relief and nutritional intake. Reduction of luminal tumor burden may improve quality of life by palliating dysphagia.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Saturday abstract Source Type: research
Dysphagia is the most common symptom in advanced esophageal cancer, and is a source of morbidity that frequently delays initiation of chemoradiation. Liquid nitrogen spray cryotherapy (LNSC) can provide rapid dysphagia relief and is postulated to stimulate a local anti-tumor immune response. Yet, no published studies have confirmed its safety when used before chemoradiotherapy. Therefore, a prospective pilot clinical trial was conducted to evaluate safety and efficacy of LNSC when administered prior to chemoradiotherapy.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Oral abstract Source Type: research
Gastroesophageal reflux disease (GERD) remains one of the most common referrals to gastroenterology and is associated with a 10-15% risk of Barrett ’s esophagus (BE). Although progression to esophageal adenocarcinoma is low in BE, current recommendations are for eradication therapy in patients found to have dysplasia on histology. Endoscopic eradication strategies range from radiofrequency ablation (RFA), photodynamic therapy, cryotherapy and endoscopic resection. The current standards in reporting BE extent via the Prague Criteria and biopsy protocol via the Seattle protocol do not address the finding of Barrett&rsq...
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Monday abstract Source Type: research
AbstractPurpose of reviewThis review discusses the durability of the neo-squamous esophageal epithelium following endoscopic eradication therapy of dysplastic Barrett ’s esophagus. Our review will focus primarily on patients treated with radiofrequency ablation; however, we describe the known durability of cryotherapy. Additionally, we discuss the utility of novel imaging technologies and the efficacy of chemopreventive medications following endoscopic ablation .Recent findingsMounting data describe the durability of the post-ablation esophagus. Dysplastic Barrett ’s esophagus and adenocarcinoma following ablat...
Source: Current Treatment Options in Gastroenterology - Category: Gastroenterology Source Type: research
This report describes the interventional bronchoscopic cryotherapy for a patient with CAO caused by squamous cell carcinoma of the esophagus. We display a series of dramatic change of chest radiographs before and after the intervention. Patient concerns: A 70-year-old man with squamous cell carcinoma of the middle third of the esophagus (initial staging, pT2N0M0; stage IIB; in January 2017) underwent Video-assisted esophagectomy and reconstruction with a gastric conduit via a substernal route. Following Chest computed tomography and positron emission tomography revealed disease progression with paratracheal metastases. ...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
Abstract In this paper, I reviewed the emerging field of endoscopic surgery and present data supporting the contention that endoscopy can now be used to treat many foregut diseases that have been traditionally treated surgically. Within each topic, the content will progress as follows: "lessons learned", "technical considerations" and "future opportunities". Lessons learned will provide a brief background and update on the most current literature. Technical considerations will include my personal experience, including tips and tricks that I have learned over the years. Finally, future...
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Tags: World J Gastroenterol Source Type: research
This study evaluated the role of oral cryotherapy for prophylaxis of oral mucositis caused by DCF therapy.MethodsWe retrospectively examined the incidence and severity of adverse events, including mucositis, in 72 patients with esophageal cancer treated with DCF. Fifty-eight patients received cryotherapy during docetaxel administration and 14 received no cryotherapy.ResultsThe incidence of mucositis of all grades and grade 3 was significantly lower in the cryotherapy group compared with the no-cryotherapy group (24.1% vs. 71.4%,P  
Source: Esophagus - Category: Gastroenterology Source Type: research
Publication date: Available online 23 November 2018Source: Best Practice &Research Clinical GastroenterologyAuthor(s): S.S. Zeki, J.J. Bergman, J.M. DunnAbstractIn the past decade there have been technological advances in Endoscopic Eradication Therapy (EET) for the management of patients with oesophageal neoplasia and early cancer. Multiple endoscopic techniques now exist for both squamous and Barrett's oesophagus associated neoplasia or early cancer. A fundamental aspect of endotherapy is removal of the target lesion by endoscopic mucosal resection, or endosopic submucosal dissection. Residual tissue is subsequently ...
Source: Best Practice and Research Clinical Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Cryotherapy | Esophagus Cancer | Marketing | Pharmaceuticals